Medsafe (New Zealand Medicines and Medical Devices Safety Authority, Ministry of Health)
Is Cagrilintide (and CagriSema) legal in New Zealand?
Not approvedCagrilintide (alone or in CagriSema) has no Medsafe consent and no data sheet in New Zealand
Not approved as a medicine here.
Medsafe's index of data sheets for consented medicines, revised 29 September 2026, lists no cagrilintide or CagriSema product. It is an investigational medicine here, and Medsafe notes that any clinical trial of a new medicine in New Zealand needs Medsafe and ethics committee approval. Without ministerial consent it cannot lawfully be sold, supplied or advertised outside narrow prescriber exemptions. Medsafe's Product/Application Search showed no cagrilintide product or application on 29 September 2026.
Last verified 2026-09-29 · how we verify
Cagrilintide (and CagriSema) elsewhere
Sources (4)
- 01Data sheets index (medicines with consent to be distributed in New Zealand)Medsafe (New Zealand Medicines and Medical Devices Safety Authority) · 2026-09-29 · accessed 2026-09-29
- 02Medicines Act 1981 (version as at 10 July 2026)New Zealand Parliamentary Counsel Office · 2026-07-10 · accessed 2026-09-29
- 03Consumer advisory: Unapproved peptide products health warningMedsafe (New Zealand Medicines and Medical Devices Safety Authority) · 2026-05-21 · accessed 2026-09-29
- 04Product/Application Search (product and application records searched by ingredient on 29 September 2026)Medsafe (New Zealand Medicines and Medical Devices Safety Authority) · 2026-07-07 · accessed 2026-09-29